Privacy Policy
Signals Blog

Contributors

Categories

.

So you’ve developed an amazing regenerative medicine device or cell therapy, or you’ve discovered a molecule that you believe could eventually be developed into a drug for awakening stem cells in the body. What’s next? For some scientists, the next step could involve becoming an entrepreneur and launching a company to commercialize your intellectual property.

There are many courses, workshops and guides on becoming an entrepreneur, and presumably lots of them offer helpful advice to get started. Before you take the plunge, this clever video about the mindset of “successful” entrepreneurs (i.e. those who have reached $100 million in revenue over five years) is worth three minutes of your time. It is based on Amy Wilkinson’s “The Creator’s Code,” (and I have no financial ties to Ms. Wilkinson or her book).

Ms. Wilkinson’s book is not specific to regenerative medicine. If you have a great discovery, be sure to get in touch with the Centre for Commercialization of Regenerative Medicine. (Yes, that was a blatant plug.)

Our regular feature, Right Turn, appears every Friday and we invite you to submit your own blog to info(at)ccrm.ca. We encourage you to be creative and use the right (!) side of your brain. We dare you to make us laugh! Right Turn features cartoons, photos, videos and other content to amuse, educate and encourage discussion.

As always, we welcome your feedback in the comment section.

The following two tabs change content below.
Avatar photo

Stacey Johnson

Stacey Johnson is the editor of Signals and a contributor. For 25 years, Stacey has been providing strategic communications counsel to government, corporate, technology and health organizations. She began her career at the CTV Television Network and then moved to Hill & Knowlton Canada where she advised clients in a variety of industries and sectors. Stacey is the Vice President, Communications and Marketing for CCRM, a leader in developing and commercializing regenerative medicine-based technologies and cell and gene therapies. She has a Master's degree in Public Relations. You can follow her on Twitter @msstaceyerin.